Catalyst Wire Dossier Catalyst Wire Dossier

LTG-321

· Latigo Biotherapeutics
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for LTG-321, covering 2026-01-23 to 2026-01-23. Get the full timeline:

Most recent: Clinical Trial Update: Phase 1 Single and Multiple Ascending Dose of LTG-321 in Healthy Participants [Phase 1]

See pricing